RULE NO.:RULE TITLE:
64B13-18.002Formulary of Topical Ocular Pharmaceutical Agents
NOTICE OF CHANGE
Notice is hereby given that the following changes have been made to the proposed rule in accordance with subparagraph 120.54(3)(d)1., F.S., published in Vol. 44 No. 185, September 21, 2018 issue of the Florida Administrative Register.
The changes are in response to discussion and subsequent vote by the board at a public hearing held September 28, 2018. The changes are as follows:
64B13-18.002 Formulary of Topical Ocular Pharmaceutical Agents
The formulary of topical ocular pharmaceutical agents consists of pharmaceutical agents that are appropriate to treat or diagnose ocular disease and disorders and which a certified optometrist is qualified to administer and prescribe in the practice of optometry pursuant to section 463.0055(2)(a), F.S. The topical ocular pharmaceutical agents in the formulary include the following legend drugs alone or in combination in concentrations up to those specified, or any lesser concentration:
(1) through (8) No change.
(9) MISCELLANEOUS
(a) through (e) No change.
(f) Natamycin Opthalmic Suspension 5%; and,
(g) Lifitegrast ophthalmic solution 5%; and,
(h) Cyclosporine 0.09% Ophthalmic Solution.
Rulemaking Authority 463.005, 463.0055(2)(a) FS. Law Implemented 463.0055 FS. History–New 3-30-87, Amended 4-5-88, 5-7-90, Formerly 21-18.002, Amended 5-10-92, 1-29-93, Formerly 21Q-18.002, Amended 8-31-93, 7-30-94, Formerly 61F8-18.002, Amended 2-11-96, 4-21-96, 1-12-97, 6-8-97, Formerly 59V-18.002, Amended 6-15-00, 6-7-05, 6-10-06, 6-26-08, 10-16-08, 3-23-09, 6-28-09, 10-18-09, 4-21-10, 12-26-10, 7-21-11, 11-11-12, 11-29-13, 12-9-13, 4-10-14, 8-14-15, 1-20-17, 8-31-18,____.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Anthony B. Spivey, Executive Director, Board of Optometry, 4052 Bald Cypress Way, Bin # C07, Tallahassee, Florida 32399-3257.
Document Information
- Related Rules: (1)
- 64B13-18.002. Formulary of Topical Ocular Pharmaceutical Agents